Development of a Critical Appraisal Tool (AIMRDA) for the Peer-Review of Studies Assessing the Anticancer Activity of Natural Products: A Step towards Reproducibility

Ahmad, Rizwan and Riaz, Muhammad and Aldholmi, Mohammed and Qureshi, Muhammad Asif and Uddin, Shahab and Bhat, Ajaz Ahmad and Poyil, Pratheeshkumar and Baig, Mukhtiar and Pourahmad, Jalal and Ganesan, Trivadi and Khan, Abdul Quaiyoom and Siddiqui, Zainab and El-Demellawy, Maha and Gholamalizadeh, Maryam and Purnomosari, Dewajani and Salim, Elsayed I and Jarrahi, Seyedeh Zahra Mousavi and Zhang, Jian-Ye and Mohammadnejad, Sammad and Jarrahi, Alireza Mosavi (2021) Development of a Critical Appraisal Tool (AIMRDA) for the Peer-Review of Studies Assessing the Anticancer Activity of Natural Products: A Step towards Reproducibility. Asian Pacific Journal of Cancer Prevention, 22 (12). 3735 – 3740. ISSN 15137368

Full text not available from this repository. (Request a copy)

Abstract

The journal of APJCP (Asian Pacific Journal of Cancer Prevention) focuses to gather relevant and up-to-date novel information's related to cancer sciences. The research methodologies and approaches adopted by the researcher are prone to variation which may be desirable in the context of novel scientific findings however, the reproducibility for these studies needs to be unified and assured. The reproducibility issues are highly concerned when preclinical studies are reported in cancer, for natural products in particular. The natural products and medicinal plants are prone to a wide variation in terms of phytochemistry and phyto-pharmacology, ultimately affecting the end results for cancer studies. Hence the need for specific guidelines to adopt a best-practice in cancer research are utmost essential. The current AIMRDA guidelines aims to develop a consensus-based tool in order to enhance the quality and assure the reproducibility of studies reporting natural products in cancer prevention. A core working committee of the experts developed an initial draft for the guidelines where more focus was kept for the inclusion of specific items not covered in previous published tools. The initial draft was peer-reviewed, experts-views provided, and improved by a scientific committee comprising of field research experts, editorial experts of different journals, and academics working in different organization worldwide. The feedback from continuous online meetings, mail communications, and webinars resulted a final draft in the shape of a checklist tool, covering the best practices related to the field of natural products research in cancer prevention and treatment. It is mandatory for the authors to read and follow the AIMRDA tool, and be aware of the good-practices to be followed in cancer research prior to any submission to APJCP. Though the tool is developed based on experts in the field, it needs to be further updated and validated in practice via implementation in the field. © 2021. All Rights Reserved.

Item Type: Article
Additional Information: Cited by: 14; All Open Access, Gold Open Access
Uncontrolled Keywords: Antineoplastic Agents; Biological Products; Consensus; Editorial Policies; Humans; Peer Review; Reproducibility of Results; Research Design; antineoplastic agent; biological product; antineoplastic activity; article; cancer prevention; cancer research; checklist; field study; human; medicinal plant; nonhuman; peer review; phytochemistry; preclinical study; reproducibility; systematic review; webinar; consensus; methodology; peer review; publishing; reproducibility
Subjects: R Medicine > RB Biomedical Sciences
Divisions: Faculty of Medicine, Public Health and Nursing > Biomedical Sciences
Depositing User: Sri JUNANDI
Date Deposited: 28 Sep 2024 03:33
Last Modified: 28 Sep 2024 03:33
URI: https://ir.lib.ugm.ac.id/id/eprint/4481

Actions (login required)

View Item
View Item